The goal of the Digestive Disease Epidemiology Training Program at the University of North Carolina at Chapel Hill is to train independent researchers who will improve our understanding of the magnitude, etiology and impact of digestive diseases, and who will assume leadership roles in GI epidemiology and outcomes research. In order to achieve this goal, the program features a comprehensive curriculum with the following features: (a) formal advanced training in epidemiologic methods and biostatistics at the UNC School of Public Health, (b) a two- to three-year period of training culminating in an advanced degree (MPH or PhD) in epidemiology, (c) emphasis on design, execution, analysis and publication of a research project, (d) a research preceptor to guide the developing investigator and (e) an intensive core curriculum designed to develop additional skills necessary for an academic career, (f) concurrent training of MD and PhD candidates. The training program will include one predoctoral and three postdoctoral candidates each year. The program takes advantage of unique and considerable institutional strengths in public health. A stable, diverse and multidisciplinary faculty provides trainees with expert guidance in epidemiology, biostatistics, decision sciences, health policy, health outcomes research and nutrition. The training faculty includes eight physicians in the UNC Division of Gastroenterology and Hepatology with advanced formal training in epidemiology and active research programs in a broad range of areas in the field of digestive disease epidemiology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007634-16
Application #
6915727
Study Section
Special Emphasis Panel (ZDK1-GRB-6 (M2))
Program Officer
Podskalny, Judith M,
Project Start
1990-07-10
Project End
2009-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
16
Fiscal Year
2005
Total Cost
$206,719
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Eluri, Swathi; Selitsky, Sara R; Perjar, Irina et al. (2018) Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol :
Leiman, D A; Kochar, B; Posner, S et al. (2018) A diagnosis of eosinophilic esophagitis is associated with increased life insurance premiums. Dis Esophagus 31:
Philpott, H; Dougherty, M K; Reed, C C et al. (2018) Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis. Aliment Pharmacol Ther 47:1071-1078
Strauss, Alexandra T; James, Theodore W; Mathews, Simon C (2018) Fellow Education Improved Through Mobile Clinical Decision Support Application: A Multi-Center Approach Involving Peri-Procedural Antithrombotic Use. Gastroenterology 155:2014-2015
Runge, Thomas M; French, Joshua B; Grimm, Ian S et al. (2018) Endoscopic repair of complete bile duct transection by use of transpapillary cholangioperitoneoscopy. VideoGIE 3:11-12
Kochar, Bharati; Barnes, Edward L; Herfarth, Hans H et al. (2018) Asians have more perianal Crohn disease and ocular manifestations compared with white Americans. Inflamm Intest Dis 2:147-153
James, Theodore W; Fan, Y Claire; Baron, Todd H (2018) EUS-guided hepaticoenterostomy as a portal to allow definitive antegrade treatment of benign biliary diseases in patients with surgically altered anatomy. Gastrointest Endosc 88:547-554
Reed, Craig C; Dellon, Evan S (2018) Patient-Reported Outcomes in Esophageal Diseases. Clin Gastroenterol Hepatol 16:305-310
Weiser, Matthew; Simon, Jeremy M; Kochar, Bharati et al. (2018) Molecular classification of Crohn's disease reveals two clinically relevant subtypes. Gut 67:36-42
Eluri, S; Klaver, E; Duits, L C et al. (2018) Validation of a biomarker panel in Barrett's esophagus to predict progression to esophageal adenocarcinoma. Dis Esophagus 31:

Showing the most recent 10 out of 238 publications